{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:20:33Z","timestamp":1790742033614,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-23516-8","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T22:08:31Z","timestamp":1763071711000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Identifying SUMOylation-related genes in liver fibrosis with bioinformatics and experimental models for diagnostic insights"],"prefix":"10.1038","volume":"15","author":[{"given":"Zhiwei","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxue","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunyan","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"issue":"2","key":"23516_CR1","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1053\/j.gastro.2018.04.034","volume":"155","author":"E Vilar-Gomez","year":"2018","unstructured":"Vilar-Gomez, E. et al. Fibrosis severity as a determinant of cause-specific mortality in patients with advanced nonalcoholic fatty liver disease: A Multi-National cohort study. Gastroenterology 155 (2), 443\u2013457 (2018).","journal-title":"Gastroenterology"},{"key":"23516_CR2","doi-asserted-by":"publisher","first-page":"615978","DOI":"10.3389\/fmed.2021.615978","volume":"8","author":"LJM Heyens","year":"2021","unstructured":"Heyens, L. J. M., Busschots, D., Koek, G. H., Robaeys, G. & Francque, S. Liver fibrosis in non-alcoholic fatty liver disease: from liver biopsy to non-invasive biomarkers in diagnosis and treatment. Front. Med. 8, 615978 (2021).","journal-title":"Front. Med."},{"key":"23516_CR3","doi-asserted-by":"crossref","unstructured":"Yan, Y., Zeng, J., Xing, L. & Li, C. Extra- and Intra-Cellular mechanisms of hepatic stellate cell activation. Biomedicines 9(8), 1014 (2021).","DOI":"10.3390\/biomedicines9081014"},{"key":"23516_CR4","doi-asserted-by":"crossref","unstructured":"Geervliet, E. & Bansal, R. Matrix metalloproteinases as potential biomarkers and therapeutic targets in liver diseases. Cells 9(5), 1212 (2020).","DOI":"10.3390\/cells9051212"},{"key":"23516_CR5","doi-asserted-by":"crossref","unstructured":"Tadokoro, T., Morishita, A. & Masaki, T. Diagnosis and therapeutic management of liver fibrosis by MicroRNA. Int J. Mol. Sci 22(15), 8139 (2021).","DOI":"10.3390\/ijms22158139"},{"key":"23516_CR6","doi-asserted-by":"crossref","unstructured":"Chang, Y., Oram, M. K. & Bielinsky, A. SUMO-Targeted ubiquitin ligases and their functions in maintaining genome stability. Int J. Mol. Sci 22(10), 5391 (2021).","DOI":"10.3390\/ijms22105391"},{"key":"23516_CR7","doi-asserted-by":"publisher","first-page":"786136","DOI":"10.3389\/fmolb.2021.786136","volume":"8","author":"PW Hotz","year":"2021","unstructured":"Hotz, P. W., M\u00fcller, S. & Mendler, L. SUMO-specific isopeptidases tuning cardiac sumoylation in health and disease. Front. Mol. Biosci. 8, 786136 (2021).","journal-title":"Front. Mol. Biosci."},{"key":"23516_CR8","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.bbrc.2021.09.066","volume":"580","author":"A Sengupta","year":"2021","unstructured":"Sengupta, A. et al. Sumoylation and its regulation in testicular Sertoli cells. Biochem. Biophys. Res. Commun. 580, 56\u201362 (2021).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"23516_CR9","doi-asserted-by":"publisher","first-page":"660494","DOI":"10.3389\/fcell.2021.660494","volume":"9","author":"Q Nie","year":"2021","unstructured":"Nie, Q. et al. The e3 ligase PIAS1 regulates p53 sumoylation to control Stress-Induced apoptosis of lens epithelial cells through the proapoptotic regulator Bax. Front. Cell. Dev. Biol. 9, 660494 (2021).","journal-title":"Front. Cell. Dev. Biol."},{"key":"23516_CR10","doi-asserted-by":"crossref","unstructured":"Tomasi, M., Cossu, C. & Ramani, K. Role of sumoylation in Alcohol-induced liver fibrosis. The FASEB Journal. 31 (S1), 602.7 (2017).","DOI":"10.1096\/fasebj.31.1_supplement.602.7"},{"key":"23516_CR11","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.toxlet.2018.03.010","volume":"289","author":"F Bu","year":"2018","unstructured":"Bu, F. et al. SENP2 alleviates CCl(4)-induced liver fibrosis by promoting activated hepatic stellate cell apoptosis and reversion. Toxicol. Lett. 289, 86\u201398 (2018).","journal-title":"Toxicol. Lett."},{"issue":"1","key":"23516_CR12","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1261\/rna.074724.120","volume":"27","author":"Y Duan","year":"2021","unstructured":"Duan, Y., Zhang, W., Cheng, Y., Shi, M. & Xia, X. A systematic evaluation of bioinformatics tools for identification of long noncoding RNAs. RNA 27 (1), 80\u201398 (2021).","journal-title":"RNA"},{"issue":"4","key":"23516_CR13","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.jhep.2007.07.006","volume":"47","author":"ZD Goodman","year":"2007","unstructured":"Goodman, Z. D. Grading and staging systems for inflammation and fibrosis in chronic liver diseases. J. Hepatol. 47 (4), 598\u2013607 (2007).","journal-title":"J. Hepatol."},{"issue":"3","key":"23516_CR14","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/hep.24127","volume":"53","author":"EM Brunt","year":"2011","unstructured":"Brunt, E. M., Kleiner, D. E., Wilson, L. A., Belt, P. & Neuschwander-Tetri, B. A. Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings. Hepatology 53 (3), 810\u2013820 (2011).","journal-title":"Hepatology"},{"issue":"D1","key":"23516_CR15","doi-asserted-by":"publisher","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","volume":"44","author":"M Kanehisa","year":"2016","unstructured":"Kanehisa, M., Sato, Y., Kawashima, M., Furumichi, M. & Tanabe, M. KEGG as a reference resource for gene and protein annotation. Nucleic Acids Res. 44 (D1), D457\u2013D462 (2016).","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"23516_CR16","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. K. E. G. G. Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28 (1), 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"23516_CR17","doi-asserted-by":"crossref","unstructured":"Caligiuri, A., Gentilini, A., Pastore, M., Gitto, S. & Marra, F. Cellular and molecular mechanisms underlying liver fibrosis regression. Cells 10(10), 2759 (2021).","DOI":"10.3390\/cells10102759"},{"key":"23516_CR18","doi-asserted-by":"publisher","first-page":"965548","DOI":"10.3389\/fimmu.2022.965548","volume":"13","author":"E Tourkochristou","year":"2022","unstructured":"Tourkochristou, E., Assimakopoulos, S. F., Thomopoulos, K., Marangos, M. & Triantos, C. NAFLD and HBV interplay - related mechanisms underlying liver disease progression. Front. Immunol. 13, 965548 (2022).","journal-title":"Front. Immunol."},{"issue":"12","key":"23516_CR19","doi-asserted-by":"publisher","first-page":"3662","DOI":"10.12998\/wjcc.v10.i12.3662","volume":"10","author":"DV Garbuzenko","year":"2022","unstructured":"Garbuzenko, D. V. Pathophysiological mechanisms of hepatic stellate cells activation in liver fibrosis. World J. Clin. Cases. 10 (12), 3662\u20133676 (2022).","journal-title":"World J. Clin. Cases"},{"key":"23516_CR20","doi-asserted-by":"publisher","first-page":"1131588","DOI":"10.3389\/fimmu.2023.1131588","volume":"14","author":"N Zhang","year":"2023","unstructured":"Zhang, N. et al. Ongoing involvers and promising therapeutic targets of hepatic fibrosis: the hepatic immune microenvironment. Front. Immunol. 14, 1131588 (2023).","journal-title":"Front. Immunol."},{"key":"23516_CR21","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.cca.2020.07.044","volume":"510","author":"M Zeng","year":"2020","unstructured":"Zeng, M., Liu, W. & Hu, Y. Fu, N. Sumoylation in liver disease. Clin. Chim. Acta. 510, 347\u2013353 (2020).","journal-title":"Clin. Chim. Acta"},{"issue":"7","key":"23516_CR22","doi-asserted-by":"publisher","first-page":"e2200065","DOI":"10.1002\/bies.202200065","volume":"44","author":"JM Enserink","year":"2022","unstructured":"Enserink, J. M. The SUMO stress response in transcriptional regulation: causal relationships or secondary bystander effects? Bioessays 44 (7), e2200065 (2022).","journal-title":"Bioessays"},{"key":"23516_CR23","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.semcdb.2020.03.008","volume":"103","author":"N Li","year":"2020","unstructured":"Li, N., Zhang, S., Xiong, F., Eizirik, D. L. & Wang, C. SUMOylation, a multifaceted regulatory mechanism in the pancreatic beta cells. Semin Cell. Dev. Biol. 103, 51\u201358 (2020).","journal-title":"Semin Cell. Dev. Biol."},{"key":"23516_CR24","doi-asserted-by":"publisher","first-page":"117607","DOI":"10.1016\/j.lfs.2020.117607","volume":"251","author":"J Dai","year":"2020","unstructured":"Dai, J. et al. Role of PML sumoylation in arsenic trioxide-induced fibrosis in HSCs. Life Sci. 251, 117607 (2020).","journal-title":"Life Sci."},{"issue":"7","key":"23516_CR25","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nrgastro.2017.38","volume":"14","author":"T Tsuchida","year":"2017","unstructured":"Tsuchida, T. & Friedman, S. L. Mechanisms of hepatic stellate cell activation. Nat. Rev. Gastroenterol. Hepatol. 14 (7), 397\u2013411 (2017).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"33","key":"23516_CR26","doi-asserted-by":"publisher","first-page":"4835","DOI":"10.3748\/wjg.v25.i33.4835","volume":"25","author":"H Zhangdi","year":"2019","unstructured":"Zhangdi, H. et al. Crosstalk network among multiple inflammatory mediators in liver fibrosis. World J. Gastroenterol. 25 (33), 4835\u20134849 (2019).","journal-title":"World J. Gastroenterol."},{"issue":"4","key":"23516_CR27","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1055\/a-1957-6384","volume":"42","author":"Y Koda","year":"2022","unstructured":"Koda, Y., Nakamoto, N. & Kanai, T. Regulation of progression and resolution of liver fibrosis by immune cells. Semin Liver Dis. 42 (4), 475\u2013488 (2022).","journal-title":"Semin Liver Dis."},{"issue":"19","key":"23516_CR28","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.21037\/atm-22-2205","volume":"10","author":"J Pan","year":"2022","unstructured":"Pan, J. et al. Exploration of immune infiltration and feature genes in viral hepatitis-associated liver fibrosis using transcriptome data. Ann. Transl Med. 10 (19), 1051 (2022).","journal-title":"Ann. Transl Med."},{"key":"23516_CR29","first-page":"20","volume":"3","author":"ML Tomasi","year":"2018","unstructured":"Tomasi, M. L. & Ramani, K. SUMOylation and phosphorylation cross-talk in hepatocellular carcinoma. Transl Gastrointest. Cancer. 3, 20 (2018).","journal-title":"Transl Gastrointest. Cancer"},{"issue":"1","key":"23516_CR30","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1038\/s41467-019-14138-6","volume":"11","author":"J Zhou","year":"2020","unstructured":"Zhou, J. et al. SUMOylation inhibitors synergize with FXR agonists in combating liver fibrosis. Nat. Commun. 11 (1), 240 (2020).","journal-title":"Nat. Commun."},{"key":"23516_CR31","doi-asserted-by":"publisher","first-page":"943683","DOI":"10.3389\/fonc.2022.943683","volume":"12","author":"L Fan","year":"2022","unstructured":"Fan, L. et al. Regulation of sumoylation targets associated with Wnt\/\u03b2-Catenin pathway. Front. Oncol. 12, 943683 (2022).","journal-title":"Front. Oncol."},{"key":"23516_CR32","doi-asserted-by":"publisher","first-page":"378","DOI":"10.3389\/fimmu.2016.00378","volume":"7","author":"B Ma","year":"2016","unstructured":"Ma, B. & Hottiger, M. O. Crosstalk between Wnt\/\u03b2-Catenin and NF-\u03baB signaling pathway during inflammation. Front. Immunol. 7, 378 (2016).","journal-title":"Front. Immunol."},{"key":"23516_CR33","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.3389\/fphar.2019.01039","volume":"10","author":"C Zhang","year":"2019","unstructured":"Zhang, C. et al. Saikosaponin-d inhibits the hepatoma cells and enhances chemosensitivity through SENP5-Dependent Inhibition of gli1 sumoylation under hypoxia. Front. Pharmacol. 10, 1039 (2019).","journal-title":"Front. Pharmacol."},{"key":"23516_CR34","doi-asserted-by":"crossref","unstructured":"Yuan, H. et al. The role of protein sumoylation in human hepatocellular carcinoma: A potential target of new drug discovery and development. Cancers 13(22), 5700 (2021).","DOI":"10.3390\/cancers13225700"},{"issue":"2","key":"23516_CR35","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1124\/mol.118.112300","volume":"94","author":"Y Yang","year":"2018","unstructured":"Yang, Y. et al. Small-Molecule inhibitors targeting protein sumoylation as novel anticancer compounds. Mol. Pharmacol. 94 (2), 885\u2013894 (2018).","journal-title":"Mol. Pharmacol."},{"key":"23516_CR36","doi-asserted-by":"crossref","unstructured":"Kukkula, A. et al. Therapeutic potential of targeting the SUMO pathway in cancer. Cancers 13(17), 4402 (2021).","DOI":"10.3390\/cancers13174402"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23516-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23516-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23516-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T22:08:32Z","timestamp":1763071712000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-23516-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["23516"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-23516-8","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,13]]},"assertion":[{"value":"9 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"39783"}}